There was a clause in the deal between Pala and Harlequin that should Dingyi buy out ELM within a certain period, Pala get 50% of the amount in excess of 34c.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025